Europe Renal Denervation Market Size & Growth Trends by 2028

Europe Renal Denervation Market Size, Share & Industry Trends Analysis Report By Technology (Radiofrequency, Ultrasound, and Micro-Infusion), By End User, By Product Type By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 78 | Format: PDF | Report ID: KBV-17897

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Renal Denervation Market, by Technology
1.4.2 Europe Renal Denervation Market, by End User
1.4.3 Europe Renal Denervation Market, by Product Type
1.4.4 Europe Renal Denervation Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Renal Denervation Market by Technology
3.1 Europe Radiofrequency Market by Country
3.2 Europe Ultrasound Market by Country
3.3 Europe Micro-Infusion Market by Country

Chapter 4. Europe Renal Denervation Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Specialty Clinics Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Renal Denervation Market by Product Type
5.1 Europe Symplicity Market by Country
5.2 Europe Enlightn Market by Country
5.3 Europe Vessix Market by Country
5.4 Europe Paradise Market by Country
5.5 Europe Iberis Market by Country
5.6 Europe Others Market by Country

Chapter 6. Europe Renal Denervation Market by Country
6.1 Germany Renal Denervation Market
6.1.1 Germany Renal Denervation Market by Technology
6.1.2 Germany Renal Denervation Market by End User
6.1.3 Germany Renal Denervation Market by Product Type
6.2 UK Renal Denervation Market
6.2.1 UK Renal Denervation Market by Technology
6.2.2 UK Renal Denervation Market by End User
6.2.3 UK Renal Denervation Market by Product Type
6.3 France Renal Denervation Market
6.3.1 France Renal Denervation Market by Technology
6.3.2 France Renal Denervation Market by End User
6.3.3 France Renal Denervation Market by Product Type
6.4 Russia Renal Denervation Market
6.4.1 Russia Renal Denervation Market by Technology
6.4.2 Russia Renal Denervation Market by End User
6.4.3 Russia Renal Denervation Market by Product Type
6.5 Spain Renal Denervation Market
6.5.1 Spain Renal Denervation Market by Technology
6.5.2 Spain Renal Denervation Market by End User
6.5.3 Spain Renal Denervation Market by Product Type
6.6 Italy Renal Denervation Market
6.6.1 Italy Renal Denervation Market by Technology
6.6.2 Italy Renal Denervation Market by End User
6.6.3 Italy Renal Denervation Market by Product Type
6.7 Rest of Europe Renal Denervation Market
6.7.1 Rest of Europe Renal Denervation Market by Technology
6.7.2 Rest of Europe Renal Denervation Market by End User
6.7.3 Rest of Europe Renal Denervation Market by Product Type

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Ablative Solutions, Inc.
7.4.1 Company Overview
7.5 Mercator MedSystems, Inc.
7.5.1 Company Overview
7.6 ReCor Medical, Inc (Otsuka Holdings Co., Ltd.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.7 Renal Dynamics Limited
7.7.1 Company Overview
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental &Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations and Agreements:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Acquisition and Mergers:

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities